Announcements and Circulars
-
- 05 Oct 2022
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
-
- 02 Sep 2022
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
-
- 26 Aug 2022
- Announcements and Notices - [Interim Results] INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
-
- 16 Aug 2022
- Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
-
- 02 Aug 2022
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
-
- 27 Jul 2022
- Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT APPROVAL OF CLINICAL TRIAL APPLICATION OF CMAB015 BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA
-
- 05 Jul 2022
- Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT APPROVAL OF CLINICAL TRIAL APPLICATION OF BIOLOGICAL CLASS I NEW DRUG CMAB017 BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA
-
- 04 Jul 2022
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
-
- 21 Jun 2022
- Announcements and Notices - [Results of AGM] SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, JUNE 17, 2022
-
- 17 Jun 2022
- Constitutional Documents SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
-
- 17 Jun 2022
- Announcements and Notices - [List of Directors and their Role and Function] LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
-
- 17 Jun 2022
- Announcements and Notices - [Results of AGM] POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, 17 JUNE 2022
-
- 06 Jun 2022
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
-
- 06 May 2022
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
-
- 21 Apr 2022
- Proxy Forms FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 17, 2022
-
- 21 Apr 2022
- Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period] NOTICE OF ANNUAL GENERAL MEETING
-
- 21 Apr 2022
- Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval / Amendment of Constitutional Documents] PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING
-
- 06 Apr 2022
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
-
- 31 Mar 2022
- Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT EXCLUSIVE PROMOTION SERVICE AGREEMENT WITH KEXING BIOPHARM REGARDING CMAB008 (INFLIXIMAB) IN MAINLAND CHINA
-
- 25 Mar 2022
- Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
-
- 25 Mar 2022
- Announcements and Notices - [Amendment of Constitutional Documents] PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION
-
- 16 Mar 2022
- Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
-
- 02 Mar 2022
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
-
- 07 Feb 2022
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
-
- 13 Jan 2022
- Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT APPROVAL OF CLINICAL TRIAL APPLICATION OF CMAB807X BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA
-
- 05 Jan 2022
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021